Globus Medical on Feb. 20 posted significant revenue growth for the fourth quarter and full year in 2023.
The company reported $616.5 million in fourth quarter sales, an increase of 124.6%, and full year sales of $1.6 billion, a 53.3% increase over the prior year, according to a news release. Globus Medical has also maintained its 2024 guidance range of $2.45 billion to $2.5 billion.
This year will be the first full year Globus Medical will be operating under its merger with NuVasive. In 2024, the company is anticipating the launch of a flagship knee robot.
Centinel Spine, a global medical device company, reported a 33% increase in year-over-year revenue during the first quarter of 2025. …
Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous…
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and…
Comments are closed.